Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate. - Abstract - Europe PMC

Europe PMC is an archive of life sciences journal literature.

INASL Guidelines on Management of Hepatitis B Virus Infection in

Once-daily tenofovir disoproxil fumarate in treatment-naive

Short-term and long-term safety and efficacy of tenofovir

Efficacy and safety of tenofovir disoproxil fumarate versus

Maternal and infant renal safety following tenofovir disoproxil

Osteoporosis and HIV Infection. - Abstract - Europe PMC

Asian-Pacific clinical practice guidelines on the management of

90-day fills for chronic hepatitis B treatments increased patient

Effects of entecavir and tenofovir disoproxil fumarate on the

KASL clinical practice guidelines for management of chronic

Switching from entecavir to tenofovir disoproxil fumarate for

Risk factors associated with hypophosphatemia in chronic Hepatitis

Treatment with β-blocker nebivolol ameliorates oxidative stress